.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
Johnson and Johnson
McKinsey
Accenture
Express Scripts
Deloitte
Citi
Dow
Healthtrust

Generated: September 23, 2017

DrugPatentWatch Database Preview

Drug Master Files for: cetirizine

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
6853AII3/10/1987UCB PHARMA SACETIRIZINE HYDROCHLORIDE
9809III8/3/1992KV PHARMACEUTICAL COCETIRIZINE HYDROCHLORIDE/PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, 10MG/240MG
15145AII11/17/2000CIPLA LTDCETIRIZINE DIHYDROCHLORIDE USP
15219III12/22/2000CAMBREX CHARLES CITY INCCETIRIZINE DIHYDROCHLORIDE
16244AII11/14/2002PERRIGO API LTDCETIRIZINE DIHYDROCHLORIDE
16262AII11/27/2002TARO PHARMACEUTICAL INDUSTRIES LTDCETIRIZINE DIHYDROCHLORIDE USP
17513AII6/18/2004UCB FARCHIM SACETIRIZINE HYDROCHLORIDE
17741AII10/8/2004MYLAN LABORATORIES LTDCETIRIZINE HYDROCHLORIDE USP
17889AII12/14/2004SUN PHARMACEUTICAL INDUSTRIES LTDCETIRIZINE DIHYDROCHLORIDE USP
18395AII5/27/2005DR REDDYS LABORATORIES LTDCETIRIZINE DIHYDROCHLORIDE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Cantor Fitzgerald
Moodys
Cipla
Covington
Julphar
Teva
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot